Genelux Stock (NASDAQ: GNLX) stock price, news, charts, stock research, profile.
Open | $3.390 |
Close | $3.320 |
Volume / Avg. | 147.726K / 138.357K |
Day Range | 3.070 - 3.410 |
52 Wk Range | 3.260 - 40.980 |
Market Cap | $95.372M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | 8.73% |
Days to Cover | 27.85 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Genelux (NASDAQ: GNLX) through any online brokerage.
Other companies in Genelux’s space includes: Anixa Biosciences (NASDAQ:ANIX), HOOKIPA Pharma (NASDAQ:HOOK), Cellectar Biosciences (NASDAQ:CLRB), Curis (NASDAQ:CRIS) and Burning Rock Biotech (NASDAQ:BNR).
The latest price target for Genelux (NASDAQ: GNLX) was reported by Benchmark on Wednesday, April 3, 2024. The analyst firm set a price target for 30.00 expecting GNLX to rise to within 12 months (a possible 745.07% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Genelux (NASDAQ: GNLX) is $3.55 last updated April 24, 2024 at 4:35 PM EDT.
There are no upcoming dividends for Genelux.
Genelux’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Genelux.
Genelux is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.